Advancing Knowledge. Enhancing Care.
Advancing Knowledge. Enhancing Care.

Psoriasis News

the latest news from ipc, industry and others

Blog

Displaying 1 to 10 of 62 Posts . Displaying 10 of Posts . Page of 7 . Go To Page: . Per Page: . . . View All Sort By: .

AbbVie Presents New Late-Breaking Data Showing SKYRIZI® (risankizumab-rzaa) Achieves Superior Rates of Complete Skin Clearance Versus COSENTYX® (secukinumab) at 52 Weeks

These new head-to-head results from the IMMerge Phase 3b open-label study were shared today during an online late-breaking presentation by the American Academy of Dermatology (AAD). AbbVie previously announced top-line results from this study in January.

Read More

Commentary: Teledermatologic monitoring for chronic cutaneous autoimmune diseases with smartworking during Covid-19 emergency in a tertiary center in Italy

Having cared for psoriasis patients via teledermatology for more than 10 years prior to the pandemic, I recognize the benefits and limitations of teledermatology for managing psoriasis. I would like to share a few practice pearls.

Read More

Commentary: The risk of respiratory tract infections and symptoms in psoriasis patients treated with IL-17-pathway inhibiting biologics

Searching for signals of increased risk of infection in specific subgroups is vitally important, especially when confronted with a severe threat to health, like the worldwide spread of the SARS-CoV-2 virus.

Read More

Stories from the Field: COVID-19 and Psoriatic Arthritis

US-based rheumatologist and IPC Councilor Arthur Kavanaugh, MD, discusses his plans to continue offering telemedicine appointments to patients after the pandemic. "Telemedicine is a new skill set that [we] providers need to learn," says Dr. Kavanaugh in this week's Stories from the Field video.

Read More

Translations NOW AVAILABLE: January 2020 Psoriasis Review Newsletter

The IPC  Psoriasis Review newsletter  provides practicing physicians with an authoritative research review that targets a range of key psoriasis publications most relevant to current clinical practice. The newsletter leverages the collective research and clinical expertise of IPC’s Councilors to identify the most important publications in psoriasis from the past year and provide a concise editorial commentary on the value of these publications. The January 2020 newsletter...

Read More

Stories from the Field: Impact of COVID-19 restrictions on psoriasis patients in Egypt

Due to COVID-19 restrictions, patients in Egypt with severe psoriasis are not getting timely access to biologic treatment. IPC Board Member Mahira Hamdy El Sayed, MSc, MD, discusses the potential fallout for Egyptians with psoriasis, post-COVID-19.

Read More

Commentary: Classification of the cutaneous manifestations of COVID-19 via a rapid consensus study in Spain

Dr. Lluís Puig provides his comments on a recent publication on the classification of the cutaneous manifestations of COVID‐19.

Read More

WATCH NOW: PsoProtect International Registry for Psoriasis and COVID-19

Catherine Smith, MD, and Savteer Mahil, MD, talk to IPC Chief Medical Officer Peter van de Kerkhof, MD, PhD, about their goals for the PsoProtect patient registry to study COVID-19 and psoriasis.

Read More

Commentary: COVID-19: risk for cytokine targeting in chronic inflammatory diseases?

Soon after COVID-19 was declared a pandemic, the question if particular patient groups – those with immune-mediated inflammatory disease (IMID) and/or those on an immunosuppressant treatment – are at higher risk to become infected and/or are at risk for developing a more severe course of the disease.

Read More

Commentary: COVID-19 in Immune-Mediated Inflammatory Diseases – Case Series from New York

Commentary from IPC Councilor Mark Lebwohl, MD, on a case series in NEJM on COVID-19 in immune-mediated inflammatory diseases.

Read More
now available

COVID-19 Psoriasis Resource Center

Information from around the world on psoriasis and coronavirus to assist dermatologists and the patients they serve

explore now

Stay informed

Join the email list to receive the latest information on psoriasis meetings, manuscripts and research.
SUBSCRIBE

Search Our Blog

  Search
 

We use cookies on this site to enhance your online experience. By continuing to use this site, you agree to accept cookies.
OK